Menu Back toS03-Collaboration-with-WHO-for-Global-Health

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S03 ]Collaboration with WHO for Global Health

Session Chair(s)

Junko  Sato, PhD

Junko Sato, PhD

  • Director, Office of International Programs
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
When facing an outbreak of socially-impactful infectious diseases such as the Ebola virus, WHO may work with pertinent regulatory agencies not only for disease containment but also on clinical studies of possible therapeutics. But other WHO activities, such as pre-qualification or reliance pathway, are of high interest in developed countries. Many observers still have the strong impression that WHO mostly works with developing countries from the global public health perspective. This session will explain what activities WHO conducts, and discuss how the industry and/or regulatory agencies can collaborate with WHO to contribute to global health.


Samvel  Azatyan, MD, PhD

Putting Reliance into Practice: WHO’s Activities on Regulatory Systems Strengthening [Recorded Presentation]

Samvel Azatyan, MD, PhD

  • Team Lead, Regulatory Convergence and Networks (RCN/REG)
  • World Health Organization (WHO), Switzerland
Agnès  Saint-Raymond, DrMed

Collaboration with WHO Global Health Medicines

Agnès Saint-Raymond, DrMed

  • Head of International Affairs Division
  • European Medicines Agency, Netherlands
Shinji  Hatakeyama

Collaboration with WHO for Global Health from Industry Perspectives

Shinji Hatakeyama

  • Director
  • Eisai Co., Ltd., Japan